Skip to content

Insulet

US · PODD #1561 by market cap Listed 1970
133.17 -4.06 -2.96%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:01

Recent news

  • Rating change
    Citigroup Maintains Neutral on Insulet, Raises Price Target to $170
    Benzinga · 2026/11/6
  • Company notice
    Insulet | SCHEDULE 13G/A: Others
    SEC · 2026/10/28
  • Company notice
    Insulet | 8-K: Insulet Reports Third Quarter 2026 Results
    SEC · 2026/11/4
  • A Quick Look at Today's Ratings for Insulet(PODD.US), With a Forecast Between $165 to $200
    Market Newswire · 2026/11/6
  • Truist Financial Maintains Insulet(PODD.US) With Hold Rating, Raises Target Price to $160
    Market Newswire · 2026/11/9
  • Company notice
    Insulet | 4: Statement of changes in beneficial ownership of securities-Officer Pease Flavia
    SEC · 2026/10/6
  • Rating change
    Barclays Maintains Equal-Weight on Insulet, Raises Price Target to $165
    Benzinga · 2026/11/7
  • Company notice
    Insulet | 10-Q: Q3 2026 Earnings Report
    SEC · 2026/11/5
  • Truist Securities Adjusts Price Target on Insulet to $160 From $153, Keeps Hold Rating
    MT Newswires · 2026/11/9
  • Rating change
    Insulet Is Maintained at Outperform by Bernstein
    Dow Jones · 2026/11/6
  • Company notice
    Insulet | SCHEDULE 13G: Others
    SEC · 2026/11/13
  • Rating change
    Insulet Price Target Raised to $167.00/Share From $143.00 by Leerink Partners
    Dow Jones · 2026/11/6
  • Rating change
    UBS Maintains Neutral on Insulet, Raises Price Target to $171
    Benzinga · 2026/11/6
  • Rating change
    Insulet Price Target Raised to $170.00/Share From $152.00 by JP Morgan
    Dow Jones · 2026/11/6
  • Barclays Maintains Insulet(PODD.US) With Hold Rating, Raises Target Price to $165
    Market Newswire · 2026/11/7
  • Rating change
    Insulet Is Maintained at Neutral by Citigroup
    Dow Jones · 2026/11/6
  • Wells Fargo Downgrades Insulet(PODD.US) to Hold Rating, Cuts Target Price to $172
    Market Newswire · 2026/11/6
  • Rating change
    Insulet Price Target Raised to $170.00/Share From $150.00 by Citigroup
    Dow Jones · 2026/11/6
  • Rating change
    JP Morgan Maintains Neutral on Insulet, Raises Price Target to $170
    Benzinga · 2026/11/6
  • Rating change
    Insulet Price Target Raised to $165.00/Share From $150.00 by Barclays
    Dow Jones · 2026/11/7
  • Rating change
    Jefferies Maintains Buy on Insulet, Lowers Price Target to $190
    Benzinga · 2026/10/13
  • Rating change
    Leerink Partners Maintains Insulet(PODD.US) With Hold Rating, Cuts Target Price to $143
    Market Newswire · 2026/10/12
  • Rating change
    Insulet Is Maintained at Buy by Jefferies
    Dow Jones · 2026/10/13
  • Rating change
    Barclays Initiates Insulet(PODD.US) With Hold Rating, Announces Target Price $150
    Market Newswire · 2026/10/8
  • Barclays Upgrades Insulet(PODD.US) to Hold Rating, Cuts Target Price to $150
    Market Newswire · 2026/10/7

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:01:08 · For reference only, not investment advice and not tailored to your situation.

Insulet discussion 0 comments

Add a comment